Full Text
PAO2- A COST-COST STUDY COMPARING ETANERCEPT WITH INFLIXIMAB IN MODERATE TO SEVERE RHEUMATOID ARTHRITIS

Abstract

Authors

MJC Nuijten PM Engelfriet KJ Duijn D Wierz M Koopmanschap

Back to Volume 3, Issue 5
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×